Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07203768 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

Study acronym: ET2PV
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from Apr 30, 2026 to Dec 31, 2026
    • Study completion pushed from Jul 31, 2026 to Dec 31, 2026
    • Study sites: 25 to 24
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 1, 2025 to Dec 1, 2025
    • Site details revised at 25 of 25 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).
Trial Details
NCT Number NCT07203768
Lead Sponsor FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Conditions
(from sponsor)		 Polycythemia Vera, Thrombocythemia
Related terms Polycythemia Vera, Thrombocytosis
Enrollment 678 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov